Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion type Assertion NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_head.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion description "[Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_provenance.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion evidence source_evidence_literature NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_provenance.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion SIO_000772 19889613 NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_provenance.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion wasDerivedFrom befree-20140225 NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_provenance.
- NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_assertion wasGeneratedBy ECO_0000203 NP651617.RA1cPGRNsyvRu_DC_LMK_YMG8O3P2NJ7fclCN40pe0Os4130_provenance.